Cosemi Secures $8M in Strategic Funding Round Dec 15, 2020 10:00AM
Bristol-Myers Squibb (BMY), Nitto Denko Enter siRNA Therapy Licensing Agreement Nov 10, 2016 07:00AM
Bristol-Myers Squibb Signs Exclusive Worldwide License Agreement with Nitto Denko for Targeted siRNA Therapy in Advanced Non-alcoholic Steatohepatitis (NASH) and Cirrhosis Due to NASH Nov 10, 2016 06:59AM